V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220009704 | 220003968 | 1.64 | 64 | Palliative (P) | null | 2016-03-13 | CETUXIMAB + IRINOTECAN + MDG | N | N | 220029097 | RUXOLITINIB |
| 220009705 | 220003968 | null | null | Palliative (P) | 2015-03-07 | 2015-03-07 | UKALL14- Ph 1 Induction + Imatinib | N | N | 220029097 | CISPLATIN + ETOPOSIDE |
| 220009706 | 220003968 | null | 48.2 | Palliative (P) | null | 2019-02-24 | Fludarabine + Melphalan RIC Allo | 99 | null | 220029097 | VINCRISTINE |
| 220009707 | 220003969 | 1.61 | null | null | 2014-04-09 | 2017-04-27 | Methotrexate Intrathecal (any age) | N | null | 220029716 | SUNITINIB |
| 220009708 | 220003970 | 1.58 | 74 | Curative (C) | 2017-12-08 | 2017-12-08 | Lenalidomide 25mg (Cycle 1 to 25) | N | N | 220029741 | ARSENIC TRIOXIDE + ATRA |
| 220009709 | 220003971 | 0 | 85.4 | Curative (C) | 2014-11-28 | 2014-12-08 | BUSULFAN + FLUDARABINE + METHOTREXATE | 02 | N | 220029875 | BEP |
| 220009710 | 220003972 | null | 85.6 | null | 2015-06-18 | 2015-06-29 | Mitomycin Intravesical | 1 | null | 220029902 | CVD |
| 220009711 | 220003973 | null | 96.3 | Palliative (P) | null | 2016-01-11 | Arsenic trioxide + Tretinoin | null | null | 220029972 | PEMETREXED |
| 220009712 | 220003974 | 1.64 | 57.5 | Palliative (P) | 2017-08-01 | 2017-08-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 220030178 | CAPECITABINE |
| 220009713 | 220003974 | null | 63 | Curative (C) | 2015-09-21 | 2015-09-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 220030178 | BEP |
| 220009714 | 220016558 | 1.65 | 6.5 | Not known (9) | 2017-05-22 | 2017-05-28 | CYTARABINE + MITOXANTRONE | N | N | 220030269 | BUSULPHAN |
| 220009715 | 220016558 | 1.67 | 0 | Curative (C) | 2016-06-09 | 2016-06-09 | IBRUTINIB | 02 | N | 220030269 | ATG + BUSULFAN + FLUDARABINE |
| 220009716 | 220016558 | 0 | 60.9 | Curative (C) | 2017-06-19 | 2018-03-26 | LANREOTIDE | N | N | 220030269 | BUSULPHAN |
| 220009717 | 220003975 | 1.68 | -1 | Palliative (P) | 2016-05-08 | 2016-05-13 | Doxorubicin + Ifosfamide | N | N | 220030597 | CAPECITABINE + CARBOPLATIN |
| 220009718 | 220003976 | 1.6 | 69 | Curative (C) | 2018-11-28 | 2018-12-14 | RUXOLITINIB | N | Y | 220030653 | BUSULFAN + FLUDARABINE + METHOTREXATE |
| 220009719 | 220003977 | null | 78.5 | Adjuvant (A) | 2016-11-07 | 2016-11-07 | Capecitabine | N | N | 220030700 | IPM |
| 220009720 | 220003978 | 0 | null | Palliative (P) | 2016-09-15 | 2016-09-20 | Capecitabine + Cisplatin | N | N | 220030714 | CISPLATIN + PEMETREXED |
| 220009721 | 220003979 | null | 68 | null | 2018-10-23 | 2018-11-06 | FCR | N | N | 220030796 | FCR |
| 220009723 | 220003981 | null | 87.2 | Curative (C) | 2015-03-10 | 2015-03-10 | BOSUTINIB | N | N | 220030969 | CHOP R |
| 220009724 | 220003981 | 1.85 | 80 | Curative (C) | 2017-10-31 | 2017-11-03 | CYTARABINE + MITOXANTRONE | Y | N | 220030969 | BUSULFAN + FLUDARABINE + METHOTREXATE |
| 220009725 | 220003981 | 1.77 | 64.8 | Not known (9) | 2017-11-07 | 2017-11-07 | LENALIDOMIDE | 02 | N | 220030969 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 220009726 | 220019102 | 1.64 | 60.2 | Disease modification (D) | 2019-03-10 | 2019-03-11 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 220031034 | LENALIDOMIDE |
| 220009727 | 220003982 | null | 0 | null | 2013-09-28 | 2013-10-03 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 2 | N | 220031066 | CISPLATIN + PEMETREXED |
| 220009728 | 220003983 | null | 72.55 | Disease modification (D) | 2014-05-08 | 2014-05-22 | RUXOLITINIB | 02 | N | 220031188 | BCG |
| 220009729 | 220012120 | 0 | 75 | Palliative (P) | 2017-01-04 | 2017-01-04 | DABRAFENIB | 2 | Y | 220031209 | OCTREOTIDE |
| 220009730 | 220003984 | 1.62 | 60.5 | Curative (C) | 2016-05-16 | 2016-05-27 | Cyclophosphamide TBI Allograft | 02 | N | 220031271 | CISPLATIN |
| 220009731 | 220003985 | 1.64 | 66.7 | Curative (C) | 2015-09-18 | 2015-09-25 | Mitoxantrone | N | N | 220031460 | ALEMTUZUMAB |
| 220009732 | 220003985 | null | 68 | Palliative (P) | null | 2016-07-09 | Cisplatin +Fluorouracil (3 wk) | N | N | 220031460 | CISPLATIN + ETOPOSIDE |
| 220009733 | 220003985 | null | 97.5 | Curative (C) | null | 2014-04-11 | Fluorouracil + Folinic Acid Weekly | null | null | 220031460 | FLUDARABINE + MELPHALAN |
| 220009734 | 220019103 | null | 63.9 | Disease modification (D) | 2017-03-30 | 2017-04-05 | DAUNORUBICIN | 2 | N | 220031655 | BOSUTINIB |
| 220009735 | 220003986 | null | 0 | Curative (C) | 2014-07-05 | 2014-07-11 | Ipilimumab | 2 | N | 220031688 | CLOFARABINE + CYTARABINE |
| 220009736 | 220003987 | 1.66 | 66.7 | Curative (C) | 2019-05-05 | 2019-05-08 | Ipilimumab | N | N | 220031810 | CISPLATIN |
| 220009737 | 220003988 | 1.6 | 49.2 | Radical (R) | 2016-04-15 | 2016-04-27 | FLA | N | N | 220032121 | CLOFARABINE + CYTARABINE |
| 220009738 | 220003989 | 1.69 | 71.1 | Curative (C) | 2017-05-06 | 2017-05-06 | BOSUTINIB | N | N | 220032124 | ATG + BUSULFAN + FLUDARABINE |
| 220009739 | 220003990 | null | null | null | 2015-09-15 | 2015-09-15 | OCTREOTIDE | null | null | 220032135 | FLUDARABINE |
| 220009740 | 220012122 | 1.48 | null | Curative (C) | 2016-10-04 | 2016-10-12 | Paclitaxel 7 day | 02 | N | 220032287 | TRIPLE INTRATHECAL |
| 220009741 | 220003991 | 1.6 | 53.5 | Curative (C) | 2014-01-12 | 2014-01-27 | RUXOLITINIB | N | N | 220032317 | UKALL2014 |
| 220009742 | 220003991 | null | 66.2 | Curative (C) | 2018-04-22 | 2018-05-28 | DABRAFENIB + TRAMETINIB | N | N | 220032317 | ARSENIC TRIOXIDE + ATRA |
| 220009743 | 220003991 | 1.67 | null | null | 2016-10-07 | 2016-10-20 | Methotrexate Intrathecal (any age) | N | N | 220032317 | CYTARABINE INTRATHECAL |
| 220009744 | 220003991 | 1.8 | 0 | Curative (C) | 2015-07-06 | 2015-07-06 | CARBOPLATIN + VINORELBINE | 02 | N | 220032317 | RUXOLITINIB |
| 220009745 | 220003991 | 1.66 | 130 | Adjuvant (A) | null | 2018-08-31 | IDARUBICIN + MITOXANTRONE + Tretinoin | N | null | 220032317 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 220009747 | 220003993 | 1.6 | 100.8 | Curative (C) | 2017-01-25 | 2017-01-25 | Bortezomib + Cyclophos + Dex | N | N | 220032710 | CARBOPLATIN + RT |
| 220009748 | 220003993 | 1.81 | 0 | Adjuvant (A) | 2016-03-06 | 2016-03-06 | Cisplatin + Paclitaxel | N | N | 220032710 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 220009749 | 220003993 | null | null | null | 2019-01-19 | 2019-01-26 | CTD | null | null | 220032710 | CYTARABINE + METHOTREXATE |
| 220009750 | 220003993 | 1.78 | 75.7 | Palliative (P) | 2017-03-08 | 2017-03-22 | CARBOPLATIN + RT | 02 | N | 220032710 | IPILIMUMAB + NIVOLUMAB |
| 220009751 | 220003994 | null | 53.7 | Curative (C) | 2017-02-28 | 2017-03-23 | Cisplatin + Paclitaxel | N | N | 220033190 | ATG + BUSULFAN + FLUDARABINE |
| 220009752 | 220012125 | null | null | Curative (C) | 2015-07-01 | 2015-07-01 | ROMAZA TRIAL | N | N | 220033254 | FLUDARABINE + MELPHALAN |
| 220009753 | 220012125 | 1.76 | 122.5 | Curative (C) | 2017-08-04 | 2017-08-16 | CAPECITABINE + TEMOZOLOMIDE | N | N | 220033254 | TRIPLE INTRATHECAL |
| 220009754 | 220019106 | 1.55 | 0 | Curative (C) | 2018-09-11 | 2018-09-17 | BOSUTINIB | N | Y | 220033355 | PEG INTERFERON |
| 220009755 | 220019106 | 1.72 | 99 | Curative (C) | 2016-12-09 | 2016-12-14 | Clofarabine + Cytarabine | N | null | 220033355 | UKALL2014 |